CenturyLink Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

CenturyLink Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,954	Closed	-$1.04M	–	30
2020 Q1	$1.04M	Sell	2,954 -88	-3%	-$32.4K	0.66%	50
2019 Q4	$1.13M	Sell	3,042 -578	-16%	-$204K	0.54%	69
2019 Q3	$1.21M	Sell	3,620 -613	-14%	-$200K	0.55%	78
2019 Q2	$1.32M	Sell	4,233 -702	-14%	-$210K	0.52%	88
2019 Q1	$1.51M	Buy	4,935 +669	+16%	+$181K	0.62%	50
2018 Q4	$991K	Buy	4,266 +586	+16%	+$157K	0.46%	112
2018 Q3	$1.15M	Sell	3,680 -440	-11%	-$137K	0.41%	106
2018 Q2	$1.19M	Buy	+4,120	New	+$1.14M	0.46%	113

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CenturyLink Investment Management's BIO Position: Q2 2020 in Review

CenturyLink Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 2,954 shares — an estimated $1.04M sold.

CenturyLink Investment Management first reported a position in BIO in Q2 2018 and held it in 8 quarters. The position peaked at $1.51M in Q1 2019. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

CenturyLink Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
CenturyLink Investment Management sold 2,954 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $1.04M.
CenturyLink Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and held it in 8 quarters.
CenturyLink Investment Management's Bio-Rad Laboratories Class A position peaked at $1.51M in Q1 2019.
469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on CenturyLink Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.